Halozyme TherapeuticsHALO
那斯達克 · USD
80.48
+1.04
(+1.31%)
收盤 02/18 04:59 (UTC+8)
盤後
80.68
+0.20
(+0.25%)
02/18 04:59 (UTC+8)
Halozyme TherapeuticsHALO
80.48
+1.04
(+1.31%)
財務數據
損益表
- 2.16
- 2.30
- 1.96
- 2.31
- 2.90
- 2.98
- 2.65
- 3.26
- 3.54
- 4.52
- -2.26
- 6.48
- -14.85
- 18.11
- 25.39
- 2.73
- -11.12
- 22.98
- 8.76
- 27.52
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | 2023/Q4 | 2023/Q3 | |
營業收入淨額 | 451,767 | 354,264 | 325,719 | 264,861 | 298,008 | 290,084 | 231,353 | 195,879 | 230,039 | 216,033 |
營業成本 | - | 55,242 | 46,359 | 48,403 | 42,055 | 49,426 | 39,607 | 28,329 | 52,298 | 54,823 |
營業毛利 | - | 299,022 | 279,360 | 216,458 | 255,953 | 240,658 | 191,746 | 167,550 | 177,741 | 161,210 |
營業費用 | - | 81,101 | 76,919 | 74,923 | 80,452 | 77,461 | - | 72,008 | 76,706 | 72,931 |
研發費用 | - | 17,251 | 17,543 | 14,799 | 20,441 | 18,458 | 21,038 | 19,111 | 21,336 | 17,321 |
推銷及管理費用 | - | 46,088 | 41,614 | 42,362 | 42,249 | 41,241 | 35,711 | 35,134 | 37,608 | 35,269 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | 17,762 | 17,762 | 17,762 | 17,762 | 17,762 | 17,762 | 17,763 | 17,762 | 20,341 |
營業利益 | -92,891 | 217,921 | 202,441 | 141,535 | 175,501 | 163,197 | 117,235 | 95,542 | 101,035 | 88,279 |
其他收入及費用 | - | 5,333 | 6,891 | 6,818 | 7,253 | 6,474 | 5,032 | 4,993 | 5,360 | 17,986 |
利息費用 | - | 4,296 | 4,394 | 4,525 | 4,540 | 4,524 | 4,524 | 4,507 | 5,220 | 4,505 |
稅前純益 | -100,849 | 218,958 | 204,938 | 143,828 | 178,214 | 165,147 | 117,743 | 96,028 | 101,175 | 101,760 |
所得稅 | 40,742 | 43,733 | 39,778 | 25,733 | 41,202 | 28,136 | 24,498 | 19,205 | 15,787 | 19,923 |
稅後純益 | -141,591 | 175,225 | 165,160 | 118,095 | 137,012 | 137,011 | 93,245 | 76,823 | 85,388 | 81,837 |
基本每股稅後盈餘(元) | -1.17 | 1.49 | 1.36 | 0.96 | 1.08 | 1.08 | 0.73 | 0.61 | - | 0.62 |
稀釋每股稅後盈餘(元) | -1.13 | 1.43 | 1.33 | 0.93 | 1.06 | 1.05 | 0.72 | 0.60 | 0.65 | 0.61 |
基本平均股數(千股) | 117583.00 | 117219.00 | 121343.00 | 123215.00 | 126406.00 | 126850.00 | 127116.00 | 126941.00 | - | 131965.00 |
稀釋平均股數(千股) | 122483.00 | 122331.00 | 124158.00 | 126644.00 | 128980.00 | 130134.00 | 129222.00 | 128887.00 | - | 134083.00 |
還原基本每股稅後盈餘(元) | -1.17 | 1.49 | 1.36 | 0.96 | 1.08 | 1.08 | 0.73 | 0.61 | - | 0.62 |
還原稀釋每股稅後盈餘(元) | -1.13 | 1.43 | 1.33 | 0.93 | 1.06 | 1.05 | 0.72 | 0.60 | 0.65 | 0.61 |
還原基本平均股數(千股) | 117,583 | 117,219 | 121,343 | 123,215 | 126,406 | 126,850 | 127,116 | 126,941 | - | 131,965 |
還原稀釋平均股數(千股) | 122,483 | 122,331 | 124,158 | 126,644 | 128,980 | 130,134 | 129,222 | 128,887 | - | 134,083 |
EBITDA(千元) | -100,849 | 245,175 | 230,552 | 168,939 | 202,615 | 188,751 | 141,399 | 120,206 | 126,427 | 129,679 |